BPC-157 (pentadecapeptide, MW ~1400 Da), Cerebrolysin (peptide mixture, varying sizes), GHK-Cu (tripeptide-copper complex, MW ~400 Da), Thymosin Beta-4 (43 amino acids, MW ~5000 Da)
A 2021 review in the journal Pharmaceuticals describes its core mechanism: PDRN binds adenosine A2A receptors on skin cells, which signals fibroblasts toward collagen synthesis, helps resolve acute inflammation, and supports granulation tissue formation
Standard Anti-Aging and Skin Rejuvenation Protocol The most commonly referenced protocol for skin quality improvement uses 1 to 2 mg of GHK-Cu administered daily via subcutaneous injection
All products are intended strictly for research use only and not for human consumption.
Thanks to this, the natural wake-rest cycle is restored